Delivery Order SPE2DB22D3004-SPE2DB25FSC14
- Not listed
- The Defense Logistics Agency awarded a $2,756.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DUOVISC Viscoelastic System 1.05ML, a specialized ophthalmic medical device. This non-competitive delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a routine fulfillment under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $10,194.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for DUOVISC Viscoelastic System 1.05ML, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime vendor agreement serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $12,792.91 to AmerisourceBergen Drug Corp for Duovisc Viscoelastic System 1.05ML, a medical ophthalmic product used in surgical procedures. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of DUOVISC Viscoelastic System 1.05ML, a specialized ophthalmic surgical product. Issued on June 18, 2025, this competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,378.05 and is scheduled for completion by June 20, 2025. The contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,667.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for DUOVISC Viscoelastic System 0.75ML, with an ultimate completion date of August 7, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,596.21 to AmerisourceBergen Drug Corp for Duovisc Viscoelastic System 1.05ML, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and utilizes a child delivery order structure under a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUOVISC Viscoelastic System (1.05mL) with a ceiling value of $3,307.32 under a firm fixed price contract type. This delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The award involved no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a $5,592.19 delivery order to AmerisourceBergen Drug Corp for the supply of Duovisc Viscoelastic System 1.05ML, with a completion date of June 20, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was issued on June 18, 2025, and the product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $4,118.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Duovisc Viscoelastic System 1.05ML, with an ultimate completion date of September 11, 2025. This non-set-aside competitive award was issued on September 10, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,512.20 to AmerisourceBergen Drug Corp for one unit of Duovisc Viscoelastic System 1.05ML, a pharmaceutical product used in ophthalmic surgical procedures. Awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, this firm fixed price delivery order represents a non-competitive, direct fulfillment from the contractor's existing DLA contract vehicle. The product will be delivered to...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSC14Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,268.30 to AmerisourceBergen Drug Corp for DUOVISC Viscoelastic System 1.05ML, a specialized ophthalmic surgical product. The contract is a firm fixed price delivery order with no set-aside designation, reflecting open competition between qualified vendors. The award was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical and medical device distributor, AmerisourceBergen serves as a critical prime vendor supporting military and federal healthcare systems. The company's contract portfolio demonstrates extensive experience delivering pharmaceutical products, medical supplies, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/21/25 |